Schistosomiasis haematobia: Clinical Trials

21 trials for Schistosomiasis haematobia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 unknown, 2 not yet recruiting, 1 withdrawn. 6 Phase 3, 4 Phase 2, 3 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Unknown 1
Phase 24Completed 3, Unknown 1
Not applicable3Completed 3
Phase 11Completed 1

Follow Schistosomiasis haematobia: new trials by email Literature Review of Schistosomiasis haematobia trials Research Report on Schistosomiasis haematobia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nanobody-based Schistosomiasis Urine Test Kit Research
Because this is an observational study, participants are not assigned an intervention as part of the study. - Schistosomiasis Haematobia
Not yet recruitingPemba Ministry of Health Zanzibar25002026-04-012026-03-30
Performance of Tests for Schistosoma Haematobium Diagnosis
S. haematobium egg detection by single urine filtration, S. haematobium egg detection by quintuple urine filtration, S. haematobium egg detection by artificial intelligence (AI) microscopy - Schistosoma Haematobium
CompletedStefanie Knopp8012025-02-102025-09-19
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.
Immunohistochemistry staining,, microscopic examination of urine - Schistosoma Haematobium
Not yet recruitingAssiut University1202023-10-012023-07-12
Anti-Schistosomiasis Sm14-vaccine in Senegal
Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium
Phase 2UnknownOswaldo Cruz Foundation1202022-07-012022-12-21
Circulating Cathodic Antigen Test Compared to Microscopy for Diagnosis of Urinary Schistosomiasis in Sohag
Urinary Schistosomiases
UnknownSohag University1002022-03-152022-04-08
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Praziquantel, Artesunate + Mefloquine - Schistosoma Haematobium, Schistosoma Mansoni
Phase 3CompletedInstitute of Tropical Medicine, Belgium7262019-10-142021-04-05
Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection
Artesunate-Pyronaridine, Artemether-Lumefantrine, Artefenomel-Ferroquine - Schistosomiasis Haematobia
Phase 2CompletedCentre de Recherche Médicale de Lambaréné542018-07-312020-02-11
The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
Companion Tablet - Schistosomiasis Haematobia
Phase 3UnknownJiangsu Institute of Parasitic Diseases1202017-04-102017-04-28
Leiden University Medical Center Mini Donor Bank
Malaria, Schistosoma Mansoni
WithdrawnLeiden University Medical Center2016-05-312017-08-29
Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)
Urine Malaria Test - Malaria
CompletedFyodor Biotechnologies Inc18932013-07-012014-04-22
Safety and Efficacy of Mirazid for Schistosomiasis Treatment
Myrrh - Schistosoma Hematobium Infection, Schistosomiasis Mansoni
Phase 3CompletedPharco Pharmaceuticals2002011-12-012015-02-20
Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal
Schistosomiasis, Anemia
CompletedBiomedical Research Center EPLS992011-10-012012-03-14
Activity of Mefloquine Against Urinary Schistosomiasis
Mefloquine, S/P - Urinary Schistosomiasis
Phase 2CompletedAlbert Schweitzer Hospital652010-05-012013-01-24
Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma
Fe-57 orally, Fe-58 intravenously - Malaria, Falciparum, Hookworm Infections
Not applicableCompletedSwiss Federal Institute of Technology432010-04-012013-10-14
Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium
Bilhvax vaccine (Sh28GST), placebo - Urinary Schistosomiasis, Schistosoma Haematobium
Phase 3CompletedInstitut National de la Santé Et de la Recherche Médicale, France2502009-02-012025-12-10
Schistosoma Haematobium Infections and Praziquantel
praziquantel - Schistosomiasis
Phase 3CompletedUniversity of Khartoum5202008-08-012013-01-17
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Artesunate+Sulfamethoxypyrazine/pyrimethamin, Praziquantel - Schistosoma Haematobium
Phase 2 / Phase 3CompletedDafra Pharma8002007-08-012008-01-18
Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
praziquantel - Hematuria, Hydronephrosis
Not applicableCompletedDBL -Institute for Health Research and Development5202004-03-012007-04-20
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
Treatment with anti-STI and anti-schistosoma regimens - Sexually Transmitted Infections, Schistosoma Haematobium
Not applicableCompletedUniversity of Aarhus6802001-08-012008-07-14
Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis
rSh28GST - Schistosomiasis, Bilharziasis
Phase 1CompletedUniversity Hospital, Lille241998-09-012013-08-27

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Schistosomiasis (7)  ·  Malaria (3)  ·  Malaria, Falciparum (2)  ·  Schistosomiasis mansoni (2)  ·  Anemia (1)  ·  Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Fever (1)  ·  Growth Disorders (1)  ·  Hematuria (1)  ·  Hookworm Infections (1)  ·  Hydronephrosis (1)

Broader conditions

Female Urogenital Diseases (21)  ·  Female Urogenital Diseases and Pregnancy Complications (21)  ·  Helminthiasis (21)  ·  Male Urogenital Diseases (21)  ·  Parasitic Diseases (21)  ·  Trematode Infections (21)  ·  Urinary Tract Infections (21)  ·  Urogenital Diseases (21)  ·  Vector Borne Diseases (21)  ·  Infections (20)  ·  Urologic Diseases (20)  ·  Schistosomiasis (14)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Mosquito-Borne Diseases (3)

Interventions

Praziquantel (6)  ·  Mefloquine (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Artesunate (1)  ·  Microscopy (1)  ·  Therapeutics (1)  ·  myrrh resin (1)  ·  pyronaridine tetraphosphate, artesunate drug combination (1)

Sponsors

Albert Schweitzer Hospital (1)  ·  Assiut University (1)  ·  Biomedical Research Center EPLS (1)  ·  Centre de Recherche Médicale de Lambaréné (1)  ·  DBL -Institute for Health Research and Development (1)  ·  Dafra Pharma (1)  ·  Fyodor Biotechnologies Inc (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Jiangsu Institute of Parasitic Diseases (1)  ·  Leiden University Medical Center (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Oswaldo Cruz Foundation (1)  ·  Pemba Ministry of Health Zanzibar (1)  ·  Pharco Pharmaceuticals (1)

Countries

Senegal (4)  ·  Egypt (3)  ·  Tanzania (3)  ·  Gabon (2)  ·  Côte d’Ivoire (1)  ·  France (1)  ·  Kenya (1)  ·  Madagascar (1)  ·  Mali (1)  ·  Mozambique (1)  ·  Nigeria (1)  ·  Sudan (1)

Top investigators

Asmaa K Abd Ellah, lecturer (1)  ·  Ayat A Haggag, MD (1)  ·  Emmanuel Hermann, PhD A.Pr. (1)  ·  Fatma G Sayed, prof (1)  ·  Gerito Augusto, Msc (1)  ·  Godwin Ntadom, MBBS, MPH (1)  ·  Kun Yang, PHD (1)  ·  Lobna Gaayeb, VetMed (1)  ·  Mahamadou S Sissoko, MD, MSPH (1)  ·  Modou Seck, MD (1)  ·  Moustapha Mbow, MD (1)

Results publications

PMID 19802383, PMID 21729382, PMID 22802974, PMID 23175561, PMID 25733630, PMID 29351649, PMID 30532268, PMID 30969960, PMID 33998661, PMID 34168029, PMID 36315579, PMID 38177851, PMID 42259467, PMID 42743322

NIH funding

2008 (1)